EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study

Janet E Pope, Jayeshkumar Patel, Christopher D Saffore, Siran Fang, Al Rasymas, Dalinda Liazoghli, Olga Ziouzina

Rheumatology and Therapy · 2026-08 · 13 (4) · 1075-1089

DOI: 10.1007/s40744-026-00859-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology and Therapy, online erschienen am 23.05.2026. Verfasst von Janet E Pope und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Rheumatology, University of Western Ontario, London, ON, Canada. janet.pope@sjhc.london.on.ca. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Axial spondyloarthritisClinical outcomesMedication persistencePatient support programPhysical function (HAQ)Psoriatic arthritisReal-world experience (RWE)Rheumatoid arthritisUpadacitinib

Autor:innen und Institutionen

  • Department of Medicine, Division of Rheumatology, University of Western Ontario, London, ON, Canada. janet.pope@sjhc.london.on.ca.
  • Rheumatology Centre, St. Joseph's Health Centre, 268 Grosvenor Street, Box 5777, London, ON, N6A 4V2, Canada. janet.pope@sjhc.london.on.ca.
  • AbbVie Inc., North Chicago, IL, USA.
  • AbbVie Corporation, Saint-Laurent, QC, Canada.
  • Division of Rheumatology, University of Calgary, Calgary, AB, Canada.

Förderung

  • AbbVie

Zitieren

APA

Pope, J. E., Patel, J., Saffore, C. D., Fang, S., Rasymas, A., Liazoghli, D., & Ziouzina, O. (2026). Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study. Rheumatology and Therapy, 13(4), 1075-1089. https://doi.org/10.1007/s40744-026-00859-w

Vancouver

Pope JE, Patel J, Saffore CD, Fang S, Rasymas A, Liazoghli D, et al. Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study. Rheumatology and Therapy. 2026;13(4):1075-1089. doi:10.1007/s40744-026-00859-w

BibTeX
@article{Pope2026,
  author = {Pope, Janet E and Patel, Jayeshkumar and Saffore, Christopher D and Fang, Siran and Rasymas, Al and Liazoghli, Dalinda and Ziouzina, Olga},
  title = {Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study},
  journal = {Rheumatology and Therapy},
  year = {2026},
  volume = {13},
  number = {4},
  pages = {1075--1089},
  doi = {10.1007/s40744-026-00859-w}
}
Kostenlos starten →